Multiple sclerosis (MS) is traditionally considered to be a prototypical autoimmune inflammatory disease of the central nervous system, with a primary immune assault aimed at central myelin and the oligodendrocyte [1][2][3][4][5][6] . In recent years, in addition to the well described inflammatory demyelinating pathology observed in this disease, progressive axonal degeneration has come to attention as an additional important component that leads to permanent and progressive clinical disability [7][8][9] . Moreover, at least in the early phases, inflammation plays a prominent role and contributes to tissue destruction. While the histopathological changes in the brain and spinal cord white matter of MS patients have been described for over a century 10,11 , more recently it is becoming apparent that gray matter structures, both cortical and deep, are involved as well [12][13][14][15] . After decades of ABSTRACT: Multiple sclerosis (MS) is traditionally considered an autoimmune inflammatory demyelinating disease of the central nervous system (CNS) with much knowledge available to support this view. However, this characterization implies that the primary event is an aberrant immune response directed at CNS antigens, promoting inflammation and later driving progressive axo-glial degeneration. Trials with potent anti-inflammatory agents and detailed neuropathological studies raise questions about this sequence of events. This hypothetical paper argues that MS may be primarily a "cytodegenerative" disease, possibly first involving the oligodendrocyte/myelin unit. Liberation of autoantigens secondarily recruits an immune response, the force of which heavily depends on the host's immune predisposition. Thus, the spectrum of MS from highly aggressive Marburg type, to primary progressive disease with little inflammatory burden, is governed by a "convolution" between the underlying cytodegeneration and the host's immune predilection. Clinical heterogeneity may be a reflection of a variable immune response, whereas in reality, the "real MS" may be a homogeneous degenerative process analogous to well known primary neurodegenerative diseases.RÉSUMÉ: La sclérose en plaques, une maladie auto-immune ou une réaction auto-immune? La sclérose en plaques (SP) est considérée traditionnellement comme une maladie démyélinisante inflammatoire auto-immune du système nerveux central (SNC), une notion bien étayée par de vastes connaissances. Cependant, cette interprétation implique que l'événement primaire est une réponse immunitaire aberrante dirigée contre des antigènes du SNC, qui favorise l'inflammation et subséquemment la dégénérescence axo-gliale progressive. Des essais au moyen d'agents anti-inflammatoires puissants et des études neuropathologiques détaillées soulèvent des questions au sujet de cette succession d'événements. Dans cet article, nous émettons l'hypothèse que la SP puisse être principalement une maladie "cytodégénérative", impliquant possiblement au départ l'unité oligodendrocyte/myéline. La libération d'auto-antigènes ...